Charles Schwab’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $96.5M | Sell |
|
|||||
|
2025
Q1 | $108M | Sell |
|
|||||
|
2024
Q4 | $131M | Buy |
|
|||||
|
2024
Q3 | $133M | Sell |
|
|||||
|
2024
Q2 | $124M | Sell |
|
|||||
|
2024
Q1 | $91.5M | Buy |
|
|||||
|
2023
Q4 | $70.2M | Buy |
|
|||||
|
2023
Q3 | $70.3M | Sell |
|
|||||
|
2023
Q2 | $73.6M | Buy |
|
|||||
|
2023
Q1 | $70.3M | Buy |
|
|||||
|
2022
Q4 | $86.7M | Buy |
|
|||||
|
2022
Q3 | $62.7M | Sell |
|
|||||
|
2022
Q2 | $93.9M | Buy |
|
|||||
|
2022
Q1 | $70.3M | Buy |
|
|||||
|
2021
Q4 | $81.8M | Buy |
|
|||||
|
2021
Q3 | $68.9M | Buy |
|
|||||
|
2021
Q2 | $66.6M | Buy |
|
|||||
|
2021
Q1 | $61.4M | Buy |
|
|||||
|
2020
Q4 | $53.2M | Buy |
|
|||||
|
2020
Q3 | $34.6M | Sell |
|
|||||
|
2020
Q2 | $41.7M | Buy |
|
|||||
|
2020
Q1 | $31.8M | Buy |
|
|||||
|
2019
Q4 | $28.8M | Buy |
|
|||||
|
2019
Q3 | $25.2M | Buy |
|
|||||
|
2019
Q2 | $17.5M | Buy |
|
|||||
|
2019
Q1 | $25.4M | Buy |
|
|||||
|
2018
Q4 | $21.8M | Buy |
|
|||||
|
2018
Q3 | $24.2M | Buy |
|
|||||
|
2018
Q2 | $20.3M | Buy |
|
|||||
|
2018
Q1 | $18.8M | Buy |
|
|||||
|
2017
Q4 | $23.4M | Buy |
|
|||||
|
2017
Q3 | $17.6M | Buy |
|
|||||
|
2017
Q2 | $18.6M | Sell |
|
|||||
|
2017
Q1 | $22.9M | Buy |
|
|||||
|
2016
Q4 | $20.7M | Buy |
|
|||||
|
2016
Q3 | $15.1M | Buy |
|
|||||
|
2016
Q2 | $13.1M | Buy |
|
|||||
|
2016
Q1 | $12.7M | Sell |
|
|||||
|
2015
Q4 | $18.7M | Buy |
|
|||||
|
2015
Q3 | $13.3M | Sell |
|
|||||
|
2015
Q2 | $22.9M | Buy |
|
|||||
|
2015
Q1 | $21.3M | Buy |
|
|||||
|
2014
Q4 | $14.2M | Sell |
|
|||||
|
2014
Q3 | $19.8M | Sell |
|
|||||
|
2014
Q2 | $22.7M | Buy |
|
|||||
|
2014
Q1 | $16.2M | Buy |
|
|||||
|
2013
Q4 | $18.6M | Buy |
|
|||||
|
2013
Q3 | $6.71M | Sell |
|
|||||
|
2013
Q2 | $10.8M | Buy |
|